Cells were labeled for 1 h with Cell Proliferation Labeling Reagent (Amersham) containing BrdU, which was diluted 1:400 in existing cell culture medium, harvested using trypsin, and fixed with 75% ethanol in phosphate-buffered saline (PBS, Gibco) overnight at -20 °C. DNA was denatured for 30 min at room temperature with 2 N hydrochloric acid, which was neutralized with 0.1 M borate buffer (pH 8.5). BrdU was detected with mouse BrdU antibody (BD Biosciences, clone B44, 1:25) and AlexaFluor® 647 anti-mouse secondary antibody (Molecular Probes, 1:200). DNA was counter-stained with 10 µg/mL propidium iodide (PI) in the presence of 50 µg/mL ribonuclease (Qiagen).
gal positive cells, at least 100 cells in two randomly selected fields from two independent replicate experiments each were scored.
Trimethylated Lysine 9 Histone H3 (H3K9me3) staining
Cryosections of the xenograft tumors were stained with anti-H3K9me3 antibody (Millipore, , followed by secondary antibody (Alexa 568 donkey-anti rabbit, Invitrogen, A10042) at the end point of the treatment study. Sections were counterstained with DAPI and observed with a Nikon Eclipse 90i microscope.
Population doubling assay
Cells were seeded at 100000 cells per well into 6-well plates one day prior to treatment with BMS-754807, PD-0332991, their combination or DMSO. Every four days, live cells as determined by Trypan blue exclusion were counted and reseeded at 100000 cells per well in drug-containing medium.
RNA interference
For transient knockdown experiments, cells were seeded into 12-well plates at 100000 cells per well one day prior to transfection with ON-TARGETplus siRNA SMARTpools against human CCND1, CDK4, CDK6, TSC2 or scrambled (siscbl) control siRNA SMARTpools (Thermo Scientific). The siRNA pools were transfected at a concentration of 50 nM using Lipofectamine® RNAiMAX reagent (Invitrogen) according to the manufacturer's instructions. Two days later, the cells were seeded into 96-well plates for sensitivity assays or 6-well plates for signaling analysis. MIA-PaCa-2 and HuP-T3 cells stably expressing non-silencing (shscbl) or two different RB1-targeting short hairpin shRNAs (shRB1-1, shRB1-2) were generated by lentiviral transduction with LKO.1 vectors containing the following oligonucleotide sequences: CCACATTATTTCTAGTCCAAA (shRB1-1, cloneID TRCN0000040163), GACTTCTACTCGAACACGAAT (shRB1-2, cloneID TRCN0000010418).
Western blotting
Western blotting was performed with standard methods. Cells treated as indicated were rinsed with ice-cold PBS and lysed in RIPA buffer (50 mM 
